refractory follicular

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . relapsed refractory AML . hormone refractory prostate cancer . refractory anemia / Follicular : follicular CD# positive . follicular dendritic cells . follicular NHL . follicular adenoma . indolent follicular non * rituximab refractory follicular . refractory follicular lymphoma *

Related by context. Frequent words. (Click for all words.) 64 follicular B 59 Relapsed 58 relapsed refractory 58 non Hodgkin lymphomas 57 Non Hodgkin Lymphoma 56 indolent NHL 56 Non Hodgkin lymphoma 55 advanced carcinoid 55 DLBCL 54 lymphoma CTCL 53 relapsed 52 refractory multiple myeloma 52 plus prednisone 52 Amrubicin 51 cell chronic lymphocytic 51 refractory 51 follicular non 51 heavily pretreated 51 superficial bladder cancer 51 follicular lymphoma 51 HRPC 50 Ofatumumab 50 refractory peripheral T 50 non Hodgkin Lymphoma 50 ZEVALIN 49 chronic lymphocytic leukemia CLL 49 HER2 positive metastatic breast 49 xenograft models 49 Acute Myeloid Leukemia AML 49 Epratuzumab 49 REVLIMID R 49 HER2 negative 49 cutaneous T cell 49 androgen independent 49 relapsed refractory multiple myeloma 48 biologic therapy 48 Voreloxin 48 HGS ETR1 48 resistant ovarian cancer 48 unresectable 48 mRCC 48 chronic HCV 48 ofatumumab 48 FavId 48 vinorelbine 48 non Hodgkin lymphoma 48 Targeted Therapy 48 NSCLC 48 cell malignancies 48 B CLL 47 metastatic renal cell carcinoma 47 registrational trial 47 temsirolimus 47 Treanda 47 secondary hyperparathyroidism 47 relapsed multiple myeloma 47 etoposide 47 refractory Hodgkin lymphoma 47 Rituximab 47 veltuzumab 47 carboplatin paclitaxel 47 registrational 47 TREANDA 47 chronic HBV infection 46 glufosfamide 46 APOPTONE 46 hepatocellular carcinoma HCC 46 gastrointestinal stromal tumors 46 liposomal formulation 46 cell lymphomas 46 refractory PTCL 46 metastatic hormone refractory 46 axitinib 46 IIa clinical trial 46 relapsing remitting multiple sclerosis 46 IIa trial 46 neoadjuvant 46 FOLFIRI 46 castration resistant prostate cancer 46 plus gemcitabine 46 IV melanoma 46 rituximab 45 acute myelogenous leukemia AML 45 tumor lysis syndrome 45 mTOR inhibitor 45 blinatumomab 45 Irinotecan 45 Herceptin trastuzumab 45 hormone refractory prostate cancer 45 goserelin 45 evaluable 45 REVLIMID ® 45 lymphomas 45 luteinizing hormone releasing 45 Pixantrone 45 Gemzar ® 45 Taxotere ® 45 romidepsin 45 Oxaliplatin 45 epirubicin 45 breast carcinoma

Back to home page